Forbes April 30, 2024
Naveen Rao

Cryptocurrency company Tether announced an investment of $200 million into Blackrock Neurotech to take a majority stake in the Brain Computer Interface (BCI) company.

As per Reuters, “The $200m deal which closed on Friday after several months of due diligence, values Blackrock Neurotech at around $350 million, making Tether its largest shareholder.”

As a neurotech company, Blackrock has been known for their longevity, bootstrapping, and heavy reliance on public funding to drive product development. Prior to this they’d only taken on $10m in VC in 2021; this deal represents a seismic shift in the company’s history.

Here’s a brief history followed by some informed speculation about what this deal might mean for the company and the field moving forward.

Who...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Investments, Medical Devices, Trends
This year's top congressional medical technology priorities
Boston Scientific to acquire devicemaker: 3 things to know
Everything You Need To Know Before Getting An RFID Implant - 3
State Licensing Spotlight - Prescription medical device manufacturers & distributors: Regulatory considerations applicable to medical devices versus drugs
Boston Scientific to buy Sonivie for up to $540M

Share This Article